Business Wire

Cognite Fuels Industrial AI Revolution with Inaugural Class of Cognite Fellows

8.5.2025 13:19:00 CEST | Business Wire | Press Release

Share

Cognite, the global leader in industrial AI, today announced the appointment of Torgrim Aas, Jan Eivind Danielsen, and Thorkild Stray as the inaugural class of Cognite Fellows. This landmark initiative underscores Cognite's deepening commitment to empowering customers with cutting-edge industrial Data and AI solutions while simultaneously building enduring know-how and competencies.

These exceptional individuals represent the vanguard of Industrial Data and AI innovation, driving the energy transition and championing responsible, scalable industrialization on a global scale—areas where Cognite continues to see increasing demand and deliver tangible results for its expanding customer base. Establishing the Cognite Fellows Program signifies the company's ongoing investment in top-tier talent and its dedication to fostering a vibrant expert community that directly benefits customers and partners.

Cognite Founder Dr. John Markus Lervik emphasized the significant contributions of the Cognite Fellows, stating, "Our first three Cognite Fellows have profoundly impacted our customers' success and are central to Cognite's competitive edge. Their work has directly boosted customer value through increased production, decreased downtime, and enhanced scalability. Innovation with the latest tech stack, driven by innovations that are meaningful on the ground within the industrial sector, is our calling, and our inaugural class well passes that threshold of requirement."

The Cognite Fellows Program recognizes individuals who embody more than just deep expertise; it celebrates their personal impact and overall contribution to the organization and its mission. Prospective Fellows are nominated by peers and evaluated based on their deep technology knowledge, creative problem-solving, innovative thinking, and technical leadership in guiding and mentoring teams and customers. Cognite Fellows must demonstrate the ability to anticipate future trends to develop impactful solutions, while being a personification of Cognite values, earning high regard across the company:

  • Torgrim Aas combines deep industrial domain experience with edge-to-cloud industrial data expertise. He has led Cognite's most challenging customer projects, showcasing exceptional technical depth and creativity, leading to significant measurable business results.
  • Jan Eivind Danielsen has a unique understanding of the industrial value chain, from capital projects to operations. Combined with his thought leadership, he has extended the use of Cognite technologies across the end-to-end industrial value chain, establishing a new industry standard.
  • Thorkild Stray has brought over two decades of experience from a variety of large-scale, real-time distributed software systems into asset-intensive industry, with a unique grit to make it work in mission-critical environments, while inspiring and mentoring colleagues and customers.

"ARC congratulates Cognite on their launch of the Cognite Fellows Program, as Cognite sets the pace as the fastest growing cloud-native industrial data platform,*" said Janice Abel, Principal Analyst, ARC Advisory Group.

The introduction of the Cognite Fellows marks another significant milestone in the company's journey, reflecting its strong momentum, commitment to innovation, and unwavering focus on delivering transformative value to its customers and partners worldwide.

About Cognite

Cognite makes GenAI work for industry. Leading energy, manufacturing, and power & renewables enterprises choose Cognite to deliver secure, trustworthy, and real-time data to transform their asset-heavy operations to be safer, more sustainable, and profitable. Cognite provides a user-friendly, secure, and scalable platform that makes it easy for all decision-makers, from the field to remote operations centers, to access and understand complex industrial data, collaborate in real-time, and build a better tomorrow. Visit us at www.cognite.com and follow us on LinkedIn and X.

* For more information on ARC's related research, visit the Operational Data Historian/Industrial Data Platform report.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250508841240/en/

Contacts

Media Contact:
Michelle Holford
Vice President, Global PR
Michelle.Holford@Cognite.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Takeda Announces Arcotatug Tavatecan (TAK-921) Demonstrated Statistically Significant and Clinically Meaningful Improvements in Overall Survival and Progression-Free Survival in Phase 3 Advanced Gastric Cancer Study23.10.2026 13:30:00 CEST | Press Release

Takeda(TSE:4502/NYSE:TAK)announced positive results from the Phase 3 G-HOPE-001 study (NCT06238843) of arcotatug tavatecan (TAK-921; Innovent R&D code: IBI343) in patients with Claudin (CLDN)18.2-positive, previously treated, advanced gastric or gastroesophageal junction adenocarcinoma (G/GEJA). Results from two prespecified interim analyses, which were shared in a late-breaking oral presentation at the 2026 European Society for Medical Oncology (ESMO) Congress, showed the study met its dual primary endpoints of overall survival (OS) and progression-free survival (PFS). Gastric cancer is a leading cause of cancer-related death worldwide, and outcomes are particularly poor once the disease is advanced.1 Because treatment options are limited for people whose cancer continues to progress after multiple therapies, there is a significant need for new targeted therapies.2 CLDN18.2, a protein found at abnormally high levels on the surface of certain cancer cells, has emerged as a key biomarke

Digital Reef Turns to Vertical Farming to Reduce Data Centre Footprint in Partnership With Elevate Farms and Xange.com to Provide Digital Measurement, Reporting and Verification of Project's Environmental Impact Within the Reef Origin Ecosystem23.10.2026 13:12:00 CEST | Press Release

Elevate Farms Inc. and Digital Reef Ltd partnership supports mitigating environmental impact of global data centre expansion establishing a framework for Digital Reef’s infrastructure pipeline to support and utilize environmental assets generated by Elevate Farms' high-yield, closed-loop vertical farming operations. Traditional agriculture supply chains are replaced with optimized indoor facilities significantly reducing food production carbon emissions, water waste and local land constraints. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261022393352/en/ Elevate Farms technology offers part of the solution to climate impact isolating food production from traditional agricultural farming variables saving over 95% of standard water requirements and significantly reducing farmland required for equivalent yields and logistical carbon. Digital Reef CEO Piers Slater stated "Digital Reef embrace data centre growth and environment

SLB Announces Third-Quarter 2026 Results23.10.2026 12:50:00 CEST | Press Release

SLB (NYSE: SLB) today announced results for the third-quarter 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261021694458/en/ The exterior of the SLB headquarters in Houston, Texas. Third-Quarter Results (Stated in millions, except per share amounts)Three Months EndedChangeSept. 30, 2026Jun. 30, 2026Sept. 30, 2025SequentialYear-on-yearRevenue $9,449 $8,972 $8,928 5% 6% Income before taxes - GAAP basis $1,019 $1,018 $1,000 0% 2% Income before taxes margin - GAAP basis 10.8% 11.4% 11.2% -57 bps -42 bps Net income attributable to SLB - GAAP basis $735 $786 $739 -6% -1% Diluted EPS - GAAP basis $0.49 $0.52 $0.50 -6% -2% Adjusted EBITDA* $2,067 $1,899 $2,061 9% - Adjusted EBITDA margin* 21.9% 21.2% 23.1% 71 bps -121 bps Pretax segment operating income* $1,576 $1,404 $1,626 12% -3% Pretax segment operating margin* 16.7% 15.6% 18.2% 104 bps -153 bps Net income attributable to SLB, excluding charges & credits* $962 $833 $1,027

EZVIZ’s Smart Entry Solutions Have Consecutively Clinched the European Product Design Award and the Golden Pin Design Award, Indicating a Shift From Home Security to Living Enjoyment23.10.2026 11:58:00 CEST | Press Release

EZVIZ’s smart lock and AI-powered doorbell remained in the spotlight after IFA for bagging two world-class awards. The EP8 Ultra AI-powered video doorbell won the European Product Design Award 2026 (EPDA 2026), keeping leading in user-centric AI. Meanwhile, the DL50FVX smart lock was named the 2026 Golden Pin Design Award (GPDA) laureate for its intuitive access management and entered the finalist of the Best Design Awards. The growing prestige of EZVIZ’s smart home access management lineup marks a new chapter of providing living experiences with multi-level interaction, modern aesthetics, and emotional care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261022441786/en/ Two representative models from EZVIZ's smart entry family take home prestigious awards for user-centric innovation. Founded in 2016, the EPDA aims to recognize well-thought-out products that break with tradition and improve everyday life. Continually refres

Galderma’s Relfydess™ (relabotulinumtoxinA) Receives Approval in China for Frown Lines23.10.2026 07:00:00 CEST | Press Release

Galderma (SIX: GALD) today announced that the Chinese NMPA has approved Relfydess for the temporary improvement of moderate-to-severe frown lines in adults, marking a significant expansion of the company’s Injectable Aesthetics portfolio in China – one of the world's largest and fastest-growing aesthetics markets.8,9 This approval follows successful authorizations and launches of Relfydess in more than 35 markets worldwide. Relfydess is the first and only ready-to-use liquid neuromodulator developed with PEARL Technology, designed to deliver a highly active, innovative, complex-free molecule that addresses the real needs of patients and healthcare professionals.1,2,4,5 It is optimized for simple volumetric dosing, without reconstitution, to increase ease-of-use and help ensure consistent dose/volume every time.1,10 At a time whenpatients and healthcare professionals are increasingly seeking high-performance neuromodulators that rapidly deliver long-lasting, natural-looking outcomes, Re

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye